{
  "id": 3026,
  "label": "Her2-receptor negative breast cancer",
  "model": {
    "label": "Mondo Disease Ontology (MONDO)",
    "source": 0
  },
  "type_id": 0,
  "reference_id": "MONDO:0000618",
  "properties": {
    "xrefs": [
      "DOID:0060080",
      "EFO:0009780",
      "MEDGEN:1684659",
      "NCIT:C168519",
      "SCTID:431396003",
      "UMLS:C4733095"
    ],
    "categories": [
      {
        "ref": "MONDO:0002657",
        "name": "breast disorder"
      }
    ]
  },
  "isLeaf": false,
  "isRoot": false,
  "child_count": 2,
  "parents": [
    {
      "id": 7684,
      "label": "breast carcinoma by gene expression profile",
      "isLeaf": false,
      "isRoot": false,
      "parents": [
        6730
      ],
      "type_id": 0,
      "properties": {
        "xrefs": [
          "EFO:1000143",
          "MEDGEN:770984",
          "NCIT:C53553",
          "UMLS:C3642344"
        ],
        "synonyms": [
          "breast carcinoma by gene expression profile"
        ],
        "categories": [
          {
            "ref": "MONDO:0002657",
            "name": "breast disorder"
          }
        ],
        "definition": "A header term that includes the following breast carcinoma subtypes determined by gene expression profiling: luminal A breast carcinoma, luminal B breast carcinoma, HER2 positive breast carcinoma, basal-like breast carcinoma, triple-negative breast carcinoma, and normal breast-like subtype of breast carcinoma."
      },
      "child_count": 8,
      "reference_id": "MONDO:0006116"
    }
  ],
  "children": [
    {
      "id": 7150,
      "label": "triple-negative breast carcinoma",
      "isLeaf": false,
      "isRoot": false,
      "parents": [
        3025,
        3026,
        8003
      ],
      "type_id": 0,
      "properties": {
        "xrefs": [
          "DOID:0060081",
          "EFO:0005537",
          "MEDGEN:1649548",
          "MESH:D064726",
          "NCIT:C71732",
          "SCTID:706970001",
          "UMLS:C4722518"
        ],
        "synonyms": [
          "triple-negative breast cancer",
          "triple-negative breast carcinoma",
          "triple-receptor negative breast cancer"
        ],
        "categories": [
          {
            "ref": "MONDO:0002657",
            "name": "breast disorder"
          }
        ],
        "definition": "An invasive breast carcinoma which is negative for expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2)."
      },
      "child_count": 3,
      "reference_id": "MONDO:0005494"
    },
    {
      "id": 24475,
      "label": "hormone receptor-positive breast cancer",
      "isLeaf": true,
      "isRoot": false,
      "parents": [
        3024,
        3026,
        8002
      ],
      "type_id": 0,
      "properties": {
        "xrefs": [
          "MEDGEN:1825950",
          "NCIT:C157056",
          "UMLS:C5442556"
        ],
        "synonyms": [
          "HR-positive HER2-negative breast cancer",
          "hormone receptor positive breast cancer"
        ],
        "categories": [
          {
            "ref": "MONDO:0002657",
            "name": "breast disorder"
          }
        ],
        "definition": "A breast carcinoma which is positive for expression of estrogen receptor (ER), progesterone receptor (PR), and is negative for expression of human epidermal growth factor receptor 2 (HER2)."
      },
      "child_count": 0,
      "reference_id": "MONDO:0700079"
    }
  ],
  "roots": [
    {
      "id": 7684,
      "label": "breast carcinoma by gene expression profile"
    }
  ]
}